Login / Signup

An in vivo study comparing efficacy of 0.25% and 0.5% bupivacaine in infraorbital nerve block for postoperative analgesia.

Aditi SahaSonal Bhavesh ShahPushkar WaknisSharvika AherPrathamesh BhujbalVibha Vaswani
Published in: Journal of dental anesthesia and pain medicine (2019)
There was no significant difference between 0.25% bupivacaine and 0.5% bupivacaine in terms of onset of action, pain during procedure, and duration of action. The use of 0.25% bupivacaine is recommended.
Keyphrases
  • pain management
  • postoperative pain
  • chronic pain
  • patients undergoing
  • minimally invasive